Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Miriam G. Mooij"'
Autor:
Tjitske M. van der Zanden, Nori J.L. Smeets, Marika de Hoop‐Sommen, Michiel F.T. Schwerzel, Hui Jun Huang, Lieke J.C. Barten, Joyce E.M. van der Heijden, Jolien J.M. Freriksen, Akira A.L. Horstink, Inge H.G. Holsappel, Miriam G. Mooij, Matthijs de Hoog, Saskia N. de Wildt
Publikováno v:
Clinical Pharmacology and Therapeutics, 112, 6, pp. 1243-1253
Clinical Pharmacology and Therapeutics, 112, 1243-1253
Clinical Pharmacology and Therapeutics, 112, 1243-1253
Contains fulltext : 287166.pdf (Publisher’s version ) (Open Access) Many drugs are still prescribed off-label to the pediatric population. Although off-label drug use not supported by high level of evidence is potentially harmful, a comprehensive o
Autor:
Adam J. Tulling, Gertjan Lugthart, Miriam G. Mooij, Caroline L.H. Brackel, Suzanne WJ Terheggen-Lagro, Rianne Oostenbrink, Corinne M.P. Buysse, Simone Hashimoto, Leontien B. van der Aa, Koen J. van Aerde, Wineke Armbrust, Bettina Auffarth-Smedema, Michiel A.G.E. Bannier, Ingeborg Y. Bart, Cherise Beek, Gitanjali I. Bechan, Jolita Bekhof, Merlijn J. van den Berg, Venje H. Boonstra, Mijke Breukels, Danielle M.C. Brinkman, Patricia Bruijning-Verhagen, Stephanie C. de Crom, Margot R. Ernst-Kruis, Pieter L. A. Fraaij, Helma B. van Gameren-Oosterom, Joyce Goris, Michael Groeneweg, Mariken Gruppen, Sanne C. Hammer, Han Hendriks, Petra C.E. Hissink Muller, Jenneke Homan-van der Veen, Marlies A. van Houten, Monique A.M. Jacobs, Lindy Janssen, Arvid W.A. Kamps, Naomi Ketharanathan, Jan W. van der Linden, Kevin H. van 't Kruys, Martijn van der Kuip, Taco Kuijpers, Ankie Lebon, Elizabeth G. Legger, Shirley Lo-A-Njoe, Meindert E. Manshande, Carien J. Miedema, Charlie C. Obihara, Lonneke van Onzenoort-Bokken, Annemarie Oudshoorn, Esther J.E. Peeters, Ronald Petru, Marielle Pijnenburg, Denise Rook, Kim Schilleman, Rian Schopmeijer, David Slotboom, Manouk van der Steen, Kim Stol, Yolande E.M. Thomasse, Wim Tissing, Gerdien A. Tramper-Stranders, Xandra W. van den Tweel, Sebastiaan J. Vastert, Mirjam van Veen, Anne B. Verbeek, Annette M.M. Vernooij-van Langen, Jantien W. Wieringa, Joanne G. Wildenbeest, Saskia N. de Wildt, Christiaan van Woerden, Erik G.J. von Asmuth, Emilie P. Buddingh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc30e8e5798ab70689e624da6d8780ed
https://doi.org/10.2139/ssrn.4401713
https://doi.org/10.2139/ssrn.4401713
Autor:
Tjitske M van der Zanden, Christoph Male, Nienke J. Vet, Saskia N. de Wildt, Florian B. Lagler, Wolfgang Rascher, Matthijs de Hoog, Helene Hartvedt Grytli, Miriam G. Mooij, Thomas Halvorsen, Antje Neubert
Publikováno v:
Clinical Pharmacology and Therapeutics, 110, 4, pp. 952-965
Clinical Pharmacology and Therapeutics
Clinical Pharmacology and Therapeutics, 110(4), 952-965. Wiley-Blackwell
Clinical Pharmacology and Therapeutics, 110, 952-965
Clinical Pharmacology and Therapeutics
Clinical Pharmacology and Therapeutics, 110(4), 952-965. Wiley-Blackwell
Clinical Pharmacology and Therapeutics, 110, 952-965
Contains fulltext : 238745.pdf (Publisher’s version ) (Open Access) A drug is granted a license for use after a thorough assessment of risks and benefits based on high-quality scientific proof of its efficacy and safety. Many drugs that are relevan
Autor:
Elisa A. M. Calvier, Saskia N. de Wildt, Elke H. J. Krekels, Miriam G. Mooij, Wouter H. J. Vaes, Dick Tibboel, Catherijne A. J. Knibbe, Niina Kleiber
Publikováno v:
Critical Care Medicine, 47, 12, pp. e975-e983
Critical Care Medicine, 47, e975-e983
Critical Care Medicine, 47(12), e975-e983
Critical Care Medicine, 47(12), E975-E983. Lippincott Williams & Wilkins
Critical care medicine, 12, 47
Critical Care Medicine, 47, e975-e983
Critical Care Medicine, 47(12), e975-e983
Critical Care Medicine, 47(12), E975-E983. Lippincott Williams & Wilkins
Critical care medicine, 12, 47
Item does not contain fulltext OBJECTIVES: Decreasing morbidity and mortality by rationalizing drug treatment in the critically ill is of paramount importance but challenging as the underlying clinical condition may lead to large variation in drug di
Autor:
Stan J. F. Hartman, Catherijne A. J. Knibbe, Joost van Rosmalen, Bianca D van Groen, Saskia N. de Wildt, N. Harry Hendrikse, Karel Allegaert, Birgit C. P. Koch, Dick Tibboel, Albert D. Windhorst, Elke H. J. Krekels, Esther van Duijn, Miriam G. Mooij, Wouter H. J. Vaes
Publikováno v:
Clinical Pharmacology and Therapeutics, 109(1), 140-149. Wiley-Blackwell
Clinical Pharmacology and Therapeutics, Epub 13 May
Clinical Pharmacology and Therapeutics, 109, 140-149
van Groen, B D, Krekels, E H J, Mooij, M G, van Duijn, E, Vaes, W H J, Windhorst, A D, van Rosmalen, J, Hartman, S J F, Hendrikse, N H, Koch, B C P, Allegaert, K, Tibboel, D, Knibbe, C A J & de Wildt, S N 2021, ' The Oral Bioavailability and Metabolism of Midazolam in Stable Critically Ill Children: A Pharmacokinetic Microtracing Study ', Clinical Pharmacology and Therapeutics, vol. 109, no. 1, pp. 140-149 . https://doi.org/10.1002/cpt.1890, https://doi.org/10.1002/cpt.1890
Clinical Pharmacology and Therapeutics
Clinical Pharmacology and Therapeutics, 109, 1, pp. 140-149
Clinical Pharmacology and Therapeutics, Epub 13 May
Clinical Pharmacology and Therapeutics, 109, 140-149
van Groen, B D, Krekels, E H J, Mooij, M G, van Duijn, E, Vaes, W H J, Windhorst, A D, van Rosmalen, J, Hartman, S J F, Hendrikse, N H, Koch, B C P, Allegaert, K, Tibboel, D, Knibbe, C A J & de Wildt, S N 2021, ' The Oral Bioavailability and Metabolism of Midazolam in Stable Critically Ill Children: A Pharmacokinetic Microtracing Study ', Clinical Pharmacology and Therapeutics, vol. 109, no. 1, pp. 140-149 . https://doi.org/10.1002/cpt.1890, https://doi.org/10.1002/cpt.1890
Clinical Pharmacology and Therapeutics
Clinical Pharmacology and Therapeutics, 109, 1, pp. 140-149
Midazolam is metabolized by the developmentally regulated intestinal and hepatic drug-metabolizing enzyme cytochrome P450 (CYP) 3A4/5. It is frequently administered orally to children, yet knowledge is lacking on the oral bioavailability in term neon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b91723dc49e8ea4eb1c1336430edfbb
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/232102
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/232102
Autor:
Bianca D, van Groen, Esther, van Duijn, Arjan, de Vries, Miriam G, Mooij, Dick, Tibboel, Wouter H J, Vaes, Saskia N, de Wildt
Publikováno v:
Clinical Pharmacology and Therapeutics
Growth and development affect drug‐metabolizing enzyme activity thus could alter the metabolic profile of a drug. Traditional studies to create metabolite profiles and study the routes of excretion are unethical in children due to the high radioact
Autor:
Hannah Batchelor, Sandra Klein, Rick Greupink, Saskia N. de Wildt, Anna Lena Ungell, Talia Flanagan, Mikko Koskinen, Ina Gesquiere, Christine M. Madla, Daniel Keszthelyi, Miriam G. Mooij, Neil Parrott, Patrick Augustijns, Abdul Basit, Cordula Stillhart, Katarina Vučićević, Goran Miljuš, Anette Müllertz, Mine Orlu, Christophe Matthys
Publikováno v:
European Journal of Pharmaceutical Sciences, 147. Elsevier
European Journal of Pharmaceutical Sciences
European Journal of Pharmaceutical Sciences, 147
Web of Science
Stillhart, C, Vucicevic, K, Augustijns, P, Basit, A W, Batchelor, H, Flanagan, T R, Gesquiere, I, Greupink, R, Keszthelyi, D, Koskinen, M, Madla, C M, Matthys, C, Miljus, G, Mooij, M G, Parrott, N, Ungell, A-L, de Wildt, S N, Orlu, M, Klein, S & Mullertz, A 2020, ' Impact of gastrointestinal physiology on drug absorption in special populations – An UNGAP review ', European Journal of Pharmaceutical Sciences, vol. 147, 105280 . https://doi.org/10.1016/j.ejps.2020.105280
European Journal of Pharmaceutical Sciences
European Journal of Pharmaceutical Sciences, 147
Web of Science
Stillhart, C, Vucicevic, K, Augustijns, P, Basit, A W, Batchelor, H, Flanagan, T R, Gesquiere, I, Greupink, R, Keszthelyi, D, Koskinen, M, Madla, C M, Matthys, C, Miljus, G, Mooij, M G, Parrott, N, Ungell, A-L, de Wildt, S N, Orlu, M, Klein, S & Mullertz, A 2020, ' Impact of gastrointestinal physiology on drug absorption in special populations – An UNGAP review ', European Journal of Pharmaceutical Sciences, vol. 147, 105280 . https://doi.org/10.1016/j.ejps.2020.105280
The release and absorption profile of an oral medication is influenced by the physicochemical properties of the drug and its formulation, as well as by the anatomy and physiology of the gastrointestinal (GI) tract. During drug development the bioavai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b41cdfd2e1abbc3a56d476417e914b82
https://pure.eur.nl/en/publications/a4c271a5-3a71-4f4c-a4ce-8319d2b6b63c
https://pure.eur.nl/en/publications/a4c271a5-3a71-4f4c-a4ce-8319d2b6b63c
Autor:
Saskia N. de Wildt, Miriam G. Mooij, Tjitske M van der Zanden, Lennard Goedknegt, I. Heleen van der Sijs, Matthijs de Hoog
Publikováno v:
Drugs & Therapy Perspectives, 36, 253-262
Drugs & Therapy Perspectives, 36, pp. 253-262
Drugs & Therapy Perspectives, 36, pp. 253-262
Calculation errors are the most common dosing errors in paediatrics. While health information technology has been advocated to improve patient safety, the broad implementation of computer-calculated dosing in the paediatric setting is delayed for the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f992e718135f17dcaa5a0211efb5c015
http://hdl.handle.net/2066/229859
http://hdl.handle.net/2066/229859
Autor:
Saskia N. de Wildt, Miriam G. Mooij, Ron H.N. van Schaik, Carin W. M. Verlaat, Dick Tibboel, Matthijs de Hoog, Nienke J. Vet, Isabel S. Jerchel, Catherijne A. J. Knibbe, Janneke M. Brussee, Birgit C. P. Koch
Publikováno v:
American Journal of Respiratory and Critical Care Medicine, 194(1), 58-66. American Thoracic Society
American Journal of Respiratory and Critical Care Medicine, 194, 1, pp. 58-66
American Journal of Respiratory and Critical Care Medicine
American Journal of Respiratory and Critical Care Medicine, 194, 58-66
American Journal of Respiratory and Critical Care Medicine, 194, 1, pp. 58-66
American Journal of Respiratory and Critical Care Medicine
American Journal of Respiratory and Critical Care Medicine, 194, 58-66
Item does not contain fulltext RATIONALE: Various in vitro, animal, and limited human adult studies suggest a profound inhibitory effect of inflammation and disease on cytochrome P-450 3A (CYP3A)-mediated drug metabolism. Studies showing this relatio
Autor:
Saskia N. de Wildt, Elke Schaeffeler, Matthias Schwab, Miriam G. Mooij, Catherijne A. J. Knibbe, Dick Tibboel, Anne T. Nies
Publikováno v:
Clinical Pharmacokinetics
Clinical Pharmacokinetics, 55(5), 507-524
Clinical Pharmacokinetics, 55(5), 507-524. Adis
Clinical Pharmacokinetics, 55, 507-24
Clinical Pharmacokinetics, 55, 5, pp. 507-24
Clinical Pharmacokinetics, 55(5), 507-524
Clinical Pharmacokinetics, 55(5), 507-524. Adis
Clinical Pharmacokinetics, 55, 507-24
Clinical Pharmacokinetics, 55, 5, pp. 507-24
Membrane transporters play an essential role in the transport of endogenous and exogenous compounds, and consequently they mediate the uptake, distribution, and excretion of many drugs. The clinical relevance of transporters in drug disposition and t